Official reprint from UpToDate®
www.uptodate.com ©2015 UpToDate®

Thymectomy for myasthenia gravis

Shawn J Bird, MD
Section Editors
Jeremy M Shefner, MD, PhD
Ira N Targoff, MD
Joseph S Friedberg, MD
Deputy Editors
John F Dashe, MD, PhD
Kathryn A Collins, MD, PhD, FACS


There are four basic therapies used to treat myasthenia gravis (MG) (table 1):

Symptomatic treatments (anticholinesterase agents)

Chronic immunomodulating treatments (glucocorticoids and other immunosuppressive drugs)

Rapid immunomodulating treatments (plasma exchange and intravenous immune globulin)

Surgical treatment (thymectomy)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2015. | This topic last updated: Jul 8, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2015 UpToDate, Inc.
  1. Silvestri NJ, Wolfe GI. Myasthenia gravis. Semin Neurol 2012; 32:215.
  2. Kim JY, Park KD, Richman DP. Treatment of myasthenia gravis based on its immunopathogenesis. J Clin Neurol 2011; 7:173.
  3. Romi F. Thymoma in myasthenia gravis: from diagnosis to treatment. Autoimmune Dis 2011; 2011:474512.
  4. Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:7.
  5. Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010; 17:893.
  6. Jani-Acsadi A, Lisak RP. Myasthenia gravis. Curr Treat Options Neurol 2010; 12:231.
  7. Kumar V, Kaminski HJ. Treatment of myasthenia gravis. Curr Neurol Neurosci Rep 2011; 11:89.
  8. Jaretzki A, Steinglass KM, Sonett JR. Thymectomy in the management of myasthenia gravis. Semin Neurol 2004; 24:49.
  9. Cea G, Benatar M, Verdugo RJ, Salinas RA. Thymectomy for non-thymomatous myasthenia gravis. Cochrane Database Syst Rev 2013; 10:CD008111.
  10. Diaz A, Black E, Dunning J. Is thymectomy in non-thymomatous myasthenia gravis of any benefit? Interact Cardiovasc Thorac Surg 2014; 18:381.
  11. Kissel JT, Franklin GM. Treatment of myasthenia gravis: A call to arms. Neurology 2000; 55:3.
  12. Mantegazza R, Baggi F, Antozzi C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 2003; 998:413.
  13. Riggs KR, Gutmann L, Riggs JE. Discordant thymectomy in identical twins concordant for myasthenia gravis. Ann Intern Med 2011; 155:478.
  14. Barnett C, Katzberg HD, Keshavjee S, Bril V. Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study. Orphanet J Rare Dis 2014; 9:214.
  15. Jaretzki A 3rd, Aarli JA, Kaminski HJ, et al. Thymectomy for myasthenia gravis: evaluation requires controlled prospective studies. Ann Thorac Surg 2003; 76:1.
  16. Shrager JB, Deeb ME, Mick R, et al. Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy. Ann Thorac Surg 2002; 74:320.
  17. Mantegazza R, Baggi F, Bernasconi P, et al. Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J Neurol Sci 2003; 212:31.
  18. Spillane J, Hayward M, Hirsch NP, et al. Thymectomy: role in the treatment of myasthenia gravis. J Neurol 2013; 260:1798.
  19. Saperstein DS, Barohn RJ. Management of myasthenia gravis. Semin Neurol 2004; 24:41.
  20. Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology 2003; 61:1652.
  21. Sonett JR, Jaretzki A 3rd. Thymectomy for nonthymomatous myasthenia gravis: a critical analysis. Ann N Y Acad Sci 2008; 1132:315.
  22. Jaretzki A 3rd, Wolff M. "Maximal" thymectomy for myasthenia gravis. Surgical anatomy and operative technique. J Thorac Cardiovasc Surg 1988; 96:711.
  23. Masaoka A. Extended trans-sternal thymectomy for myasthenia gravis. Chest Surg Clin N Am 2001; 11:369.
  24. Papatestas AE, Genkins G, Kornfeld P, et al. Transcervical thymectomy in myasthenia gravis. Surg Gynecol Obstet 1975; 140:535.
  25. Bril V, Kojic J, Ilse WK, Cooper JD. Long-term clinical outcome after transcervical thymectomy for myasthenia gravis. Ann Thorac Surg 1998; 65:1520.
  26. Calhoun RF, Ritter JH, Guthrie TJ, et al. Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg 1999; 230:555.
  27. Meyers BF, Cooper JD. Transcervical thymectomy for myasthenia gravis. Chest Surg Clin N Am 2001; 11:363.
  28. Zieliński M, Kuzdzal J, Szlubowski A, Soja J. Comparison of late results of basic transsternal and extended transsternal thymectomies in the treatment of myasthenia gravis. Ann Thorac Surg 2004; 78:253.
  29. Bachmann K, Burkhardt D, Schreiter I, et al. Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients. Surg Endosc 2008; 22:2470.
  30. Meacci E, Cesario A, Margaritora S, et al. Thymectomy in myasthenia gravis via original video-assisted infra-mammary cosmetic incision and median sternotomy: long-term results in 180 patients. Eur J Cardiothorac Surg 2009; 35:1063.
  31. Pompeo E, Tacconi F, Massa R, et al. Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis. Eur J Cardiothorac Surg 2009; 36:164.
  32. Tomulescu V, Sgarbura O, Stanescu C, et al. Ten-year results of thoracoscopic unilateral extended thymectomy performed in nonthymomatous myasthenia gravis. Ann Surg 2011; 254:761.
  33. Meyer DM, Herbert MA, Sobhani NC, et al. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches. Ann Thorac Surg 2009; 87:385.
  34. Marulli G, Rea F, Melfi F, et al. Robot-aided thoracoscopic thymectomy for early-stage thymoma: a multicenter European study. J Thorac Cardiovasc Surg 2012; 144:1125.
  35. Khicha SG, Kaiser LR, Shrager JB. Extended transcervical thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci 2008; 1132:336.
  36. Mao Z, Hu X, Lu Z, Hackett ML. Prognostic factors of remission in myasthenia gravis after thymectomy. Eur J Cardiothorac Surg 2015; 48:18.
  37. Guillermo GR, Téllez-Zenteno JF, Weder-Cisneros N, et al. Response of thymectomy: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients. Acta Neurol Scand 2004; 109:217.
  38. Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 2011; 44:36.
  39. Loach AB, Young AC, Spalding JM, Smith AC. Postoperative management after thymectomy. Br Med J 1975; 1:309.
  40. Gracey DR, Divertie MB, Howard FM Jr, Payne WS. Postoperative respiratory care after transsternal thymectomy in myasthenia gravis. A 3-year experience in 53 patients. Chest 1984; 86:67.
  41. Younger DS, Braun NM, Jaretzki A 3rd, et al. Myasthenia gravis: determinants for independent ventilation after transsternal thymectomy. Neurology 1984; 34:336.
  42. Watanabe A, Watanabe T, Obama T, et al. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 2004; 127:868.